NIPH
AMAG

NN Investment Partners Holdings’s AMAG Pharmaceuticals AMAG Stock Holding History

NN Investment Partners Holdings’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,640
Closed -$343K – 949
2017
Q2 		$343K Buy
+18,640
New +$369K ﹤0.01% 668

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NN Investment Partners Holdings's AMAG Position: Q3 2017 in Review

NN Investment Partners Holdings sold out of AMAG Pharmaceuticals (AMAG) in Q3 2017, closing a stake of 18,640 shares — an estimated $343K sold.

NN Investment Partners Holdings first reported a position in AMAG in Q2 2017 and held it in 1 quarter. The position peaked at $343K in Q2 2017. 187 funds tracked by Wall St. Rank hold AMAG as of Q3 2017.

  • NN Investment Partners Holdings reported no remaining AMAG Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • NN Investment Partners Holdings sold 18,640 AMAG Pharmaceuticals shares in Q3 2017, an estimated $343K.
  • NN Investment Partners Holdings first reported a position in AMAG Pharmaceuticals in Q2 2017 and held it in 1 quarter.
  • NN Investment Partners Holdings's AMAG Pharmaceuticals position peaked at $343K in Q2 2017.
  • 187 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2017.

Based on NN Investment Partners Holdings's 13F filing for Q3 2017, filed 13 Nov 2017.